If you like The Pharma Perspective, try…
Latest episodes
-
How Sustainable Is Your Medicine? Spain Now Prices It In | Nerea Blanque Catalina | EP 10
August 24, 2026 · 53 minGreen HTA, Spain's world-first sustainability-linked drug pricing, and why the US freeloads too: on this episode of The Pharma Perspective, pricing and market access expert Nerea Blanque Catalina explains how sustainability is becoming a…
-
Will AI Replace Medical Writers? | Virginia Chachati | EP 9
August 10, 2026 · 1 hr 5 minMedical writing rates, AI-proof writing tests, and the telltale signs of AI-generated content: on this episode of The Pharma Perspective, pharmacist turned medical writer Virginia Chachati breaks down what it takes to build a writing…
-
Most Favored Nation Pricing, Tariffs & the Rise of China | Neil Grubert | EP 8
July 27, 2026 · 1 hr 17 minMost Favored Nation (MFN) drug pricing, pharma tariffs, and China overtaking the US in new drug launches: on this episode of The Pharma Perspective, market access and policy expert Neil Grubert breaks down the forces reshaping how the…
-
Pharma's Worst Job Market in 30 Years: Top Recruiter Reveals What to Do Now | Grant Coren | EP 7
April 14, 2026 · 1 hr 9 minIn this episode of The Pharma Perspective podcast, Grant Coren, life science recruiter with over 30 years of experience and founder of his own executive search practice, discusses the state of the pharma job market in 2026, why hiring has…
-
Rethinking Medications: From Academic Detailing to Broken Drug Regulation | Jerry Avorn | EP 6
January 15, 2026 · 1 hr 5 minIn this episode of The Pharma Perspective podcast, Jerry Avorn, Professor of Medicine at Harvard Medical School and author of "Rethinking Medications," discusses the state of drug regulation in the United States, the problems with…
Show 5 more episodesShow fewer episodes
-
Measuring What Patients Actually Care About | Katja Rüdell | EP 5
January 15, 2026 · 1 hr 15 minIn this episode of The Pharma Perspective podcast, Katja Rüdell, one of the world's leading clinical outcome assessment and patient-reported outcomes experts, discusses the role of PROs in drug development, regulatory expectations from FDA…
-
What Does the ABPI Actually Do? | Jack Neill-Hall | EP 4
December 7, 2025 · 37 minIn this episode of The Pharma Perspective podcast, Jack Neill-Hall from the Association of the British Pharmaceutical Industry (ABPI) discusses the UK pharmaceutical pricing environment, NICE's cost-effectiveness threshold and appraisal…
-
Is Raising the NICE Threshold Bad for NHS Patients? | Karl Claxton | EP 3
December 7, 2025 · 54 minIn this episode of "The Pharma Perspective", I speak with Karl Claxton, Professor of Economics at the University of York and founding NICE Appraisal Committee member, about his open letter to the UK Prime Minister on pharmaceutical pricing…
-
Starting a Pharma Consultancy in a Pandemic: The PharmacoEvidence Story | Barinder Singh | EP 2
October 28, 2025 · 1 hr 12 minJoin me in my discussion with Barinder Singh, Founder of PharmacoEvidence, who quit his stable HEOR job in 2020—amid a pandemic and with a baby on the way—to start his own consultancy. In this episode of The Pharma Perspective, we explore…
-
How to Build a Meaningful Pharma Career – Leadership Lessons from a GM | Peter Wickersham | EP 1
August 17, 2025 · 51 minJoin me in my discussion with Peter Wickersham, Pharma Vice President & General Manager with 25+ years of experience, as we explore leadership, career growth, and navigating the evolving pharma industry in the age of AI. In this episode…

United States
Australia
Brazil
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom